Moreover, using an Lcn2 whole-body knockout mouse model, it was shown that lack of Lcn2 expression reduced extracellular matrix deposition, extended survival, and delayed tumor growth in both an obesity-driven genetic and an orthotopic mouse model of pancreatic cancer [27]. This evidence concerns the gene LCN2 and familial pancreatic carcinoma.